S&P 500   3,013.26 (+0.22%)
DOW   26,916.50 (+0.33%)
QQQ   193.18 (-0.11%)
AAPL   241.74 (+0.51%)
FB   183.58 (-3.26%)
MSFT   137.78 (-0.47%)
AMZN   1,774.50 (-0.62%)
CGC   20.96 (+3.00%)
NVDA   197.07 (+0.54%)
MU   45.30 (+0.18%)
BABA   170.82 (-1.56%)
GE   8.92 (+1.48%)
AMD   31.80 (-0.72%)
T   38.32 (+0.24%)
ACB   3.61 (-2.17%)
NFLX   269.50 (-3.07%)
BAC   31.25 (+0.74%)
DIS   133.41 (+2.42%)
S&P 500   3,013.26 (+0.22%)
DOW   26,916.50 (+0.33%)
QQQ   193.18 (-0.11%)
AAPL   241.74 (+0.51%)
FB   183.58 (-3.26%)
MSFT   137.78 (-0.47%)
AMZN   1,774.50 (-0.62%)
CGC   20.96 (+3.00%)
NVDA   197.07 (+0.54%)
MU   45.30 (+0.18%)
BABA   170.82 (-1.56%)
GE   8.92 (+1.48%)
AMD   31.80 (-0.72%)
T   38.32 (+0.24%)
ACB   3.61 (-2.17%)
NFLX   269.50 (-3.07%)
BAC   31.25 (+0.74%)
DIS   133.41 (+2.42%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Opko HealthTheravance BiopharmaRadius HealthG1 TherapeuticsEnanta Pharmaceuticals
SymbolNASDAQ:OPKNASDAQ:TBPHNASDAQ:RDUSNASDAQ:GTHXNASDAQ:ENTA
Price Information
Current Price$2.11$17.13$27.37$21.15$61.86
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$4.00$49.33$39.00$62.60$101.00
% Upside from Price Target89.57% upside187.99% upside42.49% upside195.98% upside63.27% upside
Trade Information
Market Cap$1.29 billion$977.04 million$1.26 billion$805.23 million$1.18 billion
Beta2.221.640.782.250.93
Average Volume3,067,328268,510544,408609,446251,659
Sales & Book Value
Annual Revenue$990.30 million$60.37 million$99.24 millionN/A$206.63 million
Price / Sales1.3116.0712.72N/A5.89
CashflowN/AN/AN/AN/A$3.94 per share
Price / CashN/AN/AN/AN/A15.71
Book Value$3.06 per share($0.93) per share$1.33 per share$9.65 per share$20.32 per share
Price / Book0.69-18.4220.58N/A3.04
Profitability
Net Income$-153,040,000.00$-215,520,000.00$-221,340,000.00$-85,290,000.00$71.95 million
EPS($0.25)($3.99)($4.88)($2.56)$3.48
Trailing P/E RatioN/AN/AN/AN/A17.78
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-26.55%-369.67%-127.22%N/A29.22%
Return on Equity (ROE)-12.17%N/A-368.58%-28.40%15.16%
Return on Assets (ROA)-8.62%-45.43%-60.65%-27.26%14.33%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.13%N/A6.75%N/AN/A
Current Ratio1.21%3.87%4.38%18.35%22.01%
Quick Ratio1.04%3.87%4.28%18.35%22.01%
Ownership Information
Institutional Ownership Percentage24.55%84.17%N/A74.94%88.61%
Insider Ownership Percentage42.25%6.60%4.00%14.49%11.35%
Miscellaneous
Employees5,69036339884113
Shares Outstanding615.60 million56.64 million46.12 million37.52 million19.68 million
Next Earnings Date11/8/2019 (Estimated)11/5/2019 (Estimated)11/7/2019 (Estimated)11/6/2019 (Estimated)11/25/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Opko HealthTheravance BiopharmaRadius HealthG1 TherapeuticsEnanta Pharmaceuticals

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel